UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 27, 2020

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-02217

COCA COLA CO

(Exact name of Registrant as specified in its charter)

Delaware

58-0628465

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

One Coca-Cola Plaza

Atlanta

Georgia

30313

(Address of principal executive offices)

(Zip Code)

Registrant's telephone number, including area code: (404) 676-2121

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.25 Par Value

KO

New York Stock Exchange

0.000% Notes Due 2021

KO21B

New York Stock Exchange

Floating Rate Notes Due 2021

KO21C

New York Stock Exchange

1.125% Notes Due 2022

KO22

New York Stock Exchange

0.125% Notes Due 2022

KO22B

New York Stock Exchange

0.75% Notes Due 2023

KO23B

New York Stock Exchange

0.500% Notes Due 2024

KO24

New York Stock Exchange

1.875% Notes Due 2026

KO26

New York Stock Exchange

0.750% Notes Due 2026

KO26C

New York Stock Exchange

1.125% Notes Due 2027

KO27

New York Stock Exchange

1.250% Notes Due 2031

KO31

New York Stock Exchange

1.625% Notes Due 2035

KO35

New York Stock Exchange

1.100% Notes Due 2036

KO36

New York Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes No

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark if the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

Indicate the number of shares outstanding of each of the issuer's classes of common stock as of the latest practicable date.

Class of Common Stock

Shares Outstanding as of April 21, 2020

$0.25 Par Value

4,294,891,353

THE COCA-COLA COMPANY AND SUBSIDIARIES

Table of Contents

Page

Forward-Looking Statements

Part I. Financial Information

Item 1.

Financial Statements (Unaudited)

Condensed Consolidated Statements of Income

Three Months Ended March 27, 2020 and March 29, 2019

Condensed Consolidated Statements of Comprehensive Income

Three Months Ended March 27, 2020 and March 29, 2019

Condensed Consolidated Balance Sheets

March 27, 2020 and December 31, 2019

Condensed Consolidated Statements of Cash Flows

Three Months Ended March 27, 2020 and March 29, 2019

Notes to Condensed Consolidated Financial Statements

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

26

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

39

Item 4.

Controls and Procedures

39

Part II. Other Information

Item 1.

Legal Proceedings

39

Item 1A.

Risk Factors

39

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

41

Item 5.

Other Information

42

Item 6.

Exhibits

42

Signatures

45

FORWARD-LOOKING STATEMENTS

This report contains information that may constitute "forward-looking statements." Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future including statements relating to volume growth, share of sales and earnings per share growth, and statements expressing general views about future operating results are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in Part II, "Item 1A. Risk Factors" and elsewhere in this report and in our Annual Report on Form 10-K for the year ended December 31, 2019, and those described from time to time in our future reports filed with the Securities and Exchange Commission.

Part I. Financial Information

Item 1. Financial Statements (Unaudited)

THE COCA-COLA COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(UNAUDITED)

(In millions except per share data)

Three Months Ended

March 27,

2020

March 29,

2019

Net Operating Revenues

8,601

8,694

Cost of goods sold

3,371

3,365

Gross Profit

5,230

5,329

Selling, general and administrative expenses

2,648

2,767

Other operating charges

202

127

Operating Income

2,380

2,435

Interest income

112

133

Interest expense

193

245

Equity income (loss) net

167

133

Other income (loss) net

544

(231

Income Before Income Taxes

3,010

2,225

Income taxes

215

522

Consolidated Net Income

2,795

1,703

Less: Net income (loss) attributable to noncontrolling interests

20

25

Net Income Attributable to Shareowners of The Coca-Cola Company

2,775

1,678

Basic Net Income Per Share1

0.65

0.39

Diluted Net Income Per Share1

0.64

0.39

Average Shares Outstanding

4,289

4,271

Effect of dilutive securities

36

35

Average Shares Outstanding Assuming Dilution

4,325

4,306

1 Calculated based on net income attributable to shareowners of The Coca-Cola Company.

Refer to Notes to Condensed Consolidated Financial Statements.

THE COCA-COLA COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

(In millions)

Three Months Ended

March 27,

2020

March 29,

2019

Consolidated Net Income

2,795

1,703

Other Comprehensive Income:

Net foreign currency translation adjustments

(2,621

926

Net gains (losses) on derivatives

16

Net change in unrealized gains (losses) on available-for-sale debt securities

(8

15

Net change in pension and other benefit liabilities

31

Total Comprehensive Income

188

2,683

Less: Comprehensive income (loss) attributable to noncontrolling interests

(435

(3

Total Comprehensive Income Attributable to Shareowners of The Coca-Cola Company

623

2,686

Refer to Notes to Condensed Consolidated Financial Statements.

THE COCA-COLA COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(In millions except par value)

March 27,

2020

December 31,

2019

ASSETS

Current Assets

Cash and cash equivalents

13,561

6,480

Short-term investments

1,713

1,467

Total Cash, Cash Equivalents and Short-Term Investments

15,274

7,947

Marketable securities

2,392

3,228

Trade accounts receivable, less allowances of $527 and $524, respectively

4,430

3,971

Inventories

3,558

3,379

Prepaid expenses and other assets

2,580

1,886

Total Current Assets

28,234

20,411

Equity method investments

18,020

19,025

Other investments

652

854

Other assets

6,001

6,075

Deferred income tax assets

2,275

2,412

Property, plant and equipment, less accumulated depreciation of

$8,285 and $8,083, respectively

10,993

10,838

Trademarks with indefinite lives

10,457

9,266

Bottlers' franchise rights with indefinite lives

108

109

Goodwill

16,673

16,764

Other intangible assets

600

627

Total Assets

94,013

86,381

LIABILITIES AND EQUITY

Current Liabilities

Accounts payable and accrued expenses

12,640

11,312

Loans and notes payable

13,657

10,994

Current maturities of long-term debt

5,642

4,253

Accrued income taxes

458

414

Total Current Liabilities

32,397

26,973

Long-term debt

31,094

27,516

Other liabilities

8,832

8,510

Deferred income tax liabilities

1,856

2,284

The Coca-Cola Company Shareowners' Equity

Common stock, $0.25 par value; authorized 11,200 shares; issued 7,040 shares

1,760

1,760

Capital surplus

17,312

17,154

Reinvested earnings

66,870

65,855

Accumulated other comprehensive income (loss)

(15,696

(13,544

Treasury stock, at cost 2,746 and 2,760 shares, respectively

(52,088

(52,244

Equity Attributable to Shareowners of The Coca-Cola Company

18,158

18,981

Equity attributable to noncontrolling interests

1,676

2,117

Total Equity

19,834

21,098

Total Liabilities and Equity

94,013

86,381

Refer to Notes to Condensed Consolidated Financial Statements.

THE COCA-COLA COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(In millions)

Three Months Ended

March 27,

2020

March 29,

2019

Operating Activities

Consolidated net income

2,795

1,703

Depreciation and amortization

367

275

Stock-based compensation expense

(5

40

Deferred income taxes

(122

122

Equity (income) loss net of dividends

(157

(120

Foreign currency adjustments

(59

(39

Significant (gains) losses net

(919

87

Other operating charges

190

55

Other items

235

147

Net change in operating assets and liabilities

(1,769

(1,482

Net Cash Provided by Operating Activities

556

788

Investing Activities

Purchases of investments

(1,455

(1,062

Proceeds from disposals of investments

1,603

1,994

Acquisitions of businesses, equity method investments and nonmarketable securities

(984

(5,322

Proceeds from disposals of businesses, equity method investments and nonmarketable securities

36

261

Purchases of property, plant and equipment

(327

(388

Proceeds from disposals of property, plant and equipment

91

27

Other investing activities

(48

31

Net Cash Provided by (Used in) Investing Activities

(1,084

(4,459

Financing Activities

Issuances of debt

12,563

10,256

Payments of debt

(4,833

(9,652

Issuances of stock

413

190

Purchases of stock for treasury

(94

(397

Other financing activities

(239

24

Net Cash Provided by (Used in) Financing Activities

7,810

421

Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

(54

56

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents

during the period

7,228

(3,194

Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period

6,737

9,318

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at End of Period

13,965

6,124

Less: Restricted cash and restricted cash equivalents at end of period

404

276

Cash and Cash Equivalents at End of Period

13,561

5,848

Refer to Notes to Condensed Consolidated Financial Statements.

THE COCA-COLA COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by U.S. GAAP for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2019.

When used in these notes, the terms "The Coca-Cola Company," "Company," "we," "us" and "our" mean The Coca-Cola Company and all entities included in our condensed consolidated financial statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 27, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. Sales of our nonalcoholic ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of sales in the beverage business may be affected by weather conditions.

Each of our interim reporting periods, other than the fourth interim reporting period, ends on the Friday closest to the last day of the corresponding quarterly calendar period. The first quarter of 2020 and the first quarter of 2019 ended on March 27, 2020 and March 29, 2019, respectively. Our fourth interim reporting period and our fiscal year end on December 31 regardless of the day of the week on which December 31 falls.

Advertising Costs

The Company's accounting policy related to advertising costs for annual reporting purposes is to expense production costs of print, radio, television and other advertisements as of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred.

For interim reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple interim periods to each of our interim reporting periods. We use the proportion of each interim period's actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being recognized at a standard rate per unit case. At the end of each interim reporting period, we review our estimated full year unit case volume and our estimated full year marketing expenditures that benefit multiple interim periods in order to evaluate if a change in estimate is necessary. The impact of any changes in these full year estimates is recognized in the interim period in which the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents

We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents or restricted cash equivalents, as applicable. Restricted cash and restricted cash equivalents generally consist of amounts held by our captive insurance companies, which are included in the line item other assets on our consolidated balance sheet, and amounts classified in assets held for sale. We manage our exposure to counterparty credit risk through specific minimum credit standards, diversification of counterparties and procedures to monitor our concentrations of credit risk.

The following table provides a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in the condensed consolidated statements of cash flows (in millions):

March 27,

2020

December 31,

2019

Cash and cash equivalents

13,561

6,480

Cash and cash equivalents included in other assets1

404

257

Cash, cash equivalents, restricted cash and restricted cash equivalents

13,965

6,737

March 29,

2019

December 31, 2018

Cash and cash equivalents

5,848

9,077

Cash and cash equivalents included in other assets1

276

241

Cash, cash equivalents, restricted cash and restricted cash equivalents

6,124

9,318

1 Amounts represent cash and cash equivalents in our solvency capital portfolio set aside primarily to cover pension obligations in certain of

our European and Canadian pension plans. Refer to Note 4.

Recently Issued Accounting Guidance

In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2019-12, Simplifying the Accounting for Income Taxes, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating taxes during the quarters and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the accounting for franchise taxes, enacts changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for the Company beginning January 1, 2021 and would require us to recognize a cumulative effect adjustment to the opening balance of reinvested earnings, if applicable. We are currently evaluating the impact that ASU 2019-12 may have on our consolidated financial statements.

NOTE 2: ACQUISITIONS AND DIVESTITURES

Acquisitions

During the three months ended March 27, 2020, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $984 million, which primarily related to the acquisition of the remaining equity ownership interest in fairlife, LLC ("fairlife").

During the three months ended March 29, 2019, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $5,322 million, which primarily related to the acquisition of Costa Limited ("Costa"), the remaining equity ownership interest in C.H.I. Limited ("CHI") and controlling interests in bottling operations in Zambia.

fairlife, LLC

In January 2020, the Company acquired the remaining 57.5 percent interest in, and now owns 100 percent of, fairlife. fairlife offers a broad portfolio of products in the value-added dairy category across North America. A significant portion of fairlife's revenues was already reflected in our consolidated financial statements, as we have operated as the sales and distribution organization for certain fairlife products. Upon consolidation, we recognized a gain of $902 million resulting from the remeasurement of our previously held equity interest in fairlife to fair value. The fair value of our previously held interest was determined using a discounted cash flow model based on Level 3 inputs. The gain was recorded in the line item other income (loss) net in our condensed consolidated statement of income. We acquired the remaining interest in exchange for $979 million of cash, net of cash acquired, and effectively settled our $306 million note receivable from fairlife at the recorded amount. Under the terms of the agreement, we are subject to making future milestone payments which are contingent on fairlife achieving certain financial targets through 2024, and if achieved, are payable in 2021, 2023 and 2025. These milestone payments are based on agreed-upon formulas related to fairlife's operating results, the resulting value of which is not subject to a ceiling. Under the applicable accounting guidance, we recorded a $270 million liability representing our best estimate of the fair value of this contingent consideration. The fair value of this contingent consideration was determined using a Monte Carlo valuation model based on Level 3 inputs. We will be required to remeasure this liability to fair value quarterly with any changes in the fair value recorded in income until the final milestone payments are made. During the three months ended March 27, 2020, we recorded a charge of $11 million related to this remeasurement in the line item other operating charges in our condensed consolidated statement of income. As of March 27, 2020, $1.3 billion of the purchase price was preliminarily allocated to the fairlife trademark and $0.8 billion was preliminarily allocated to goodwill. The goodwill recognized as part of this acquisition is primarily related to synergistic value created from the opportunity for additional expansion. It also includes certain other intangible assets that do not qualify for separate recognition, such as an assembled workforce. The goodwill is not tax deductible and has been preliminarily assigned to the North America operating segment. The preliminary allocation of the

purchase price is subject to refinement when valuations are finalized. As of March 27, 2020, the valuations that have not been finalized primarily relate to the trademark and other intangible assets; property, plant and equipment; and operating lease right-of-use ("ROU") assets and operating lease liabilities. The final purchase price allocation will be completed no later than the first quarter of 2021.

Costa Limited

In January 2019, the Company acquired Costa in exchange for $4.9 billion of cash, net of cash acquired. Costa is a coffee business with retail outlets in more than 30 countries, the Costa Express vending system and a state-of-the-art roastery. We believe this acquisition will allow us to increase our presence in the hot beverage market as Costa has a scalable platform across multiple formats and channels, including opportunities to introduce ready-to-drink products. Upon finalization of purchase accounting, $2.4 billion of the purchase price was allocated to the Costa trademark and $2.5 billion was allocated to goodwill. The goodwill recognized as part of this acquisition is primarily related to synergistic value created from the opportunity for additional expansion as well as our ability to market and distribute Costa in ready-to-drink form throughout our bottling system. It also includes certain other intangible assets that do not qualify for separate recognition, such as an assembled workforce. The goodwill is not tax deductible and has been assigned to the Global Ventures operating segment, except for $108 million, which was allocated to the Europe, Middle East and Africa operating segment.

C.H.I. Limited

In January 2019, the Company acquired the remaining 60 percent interest in CHI, a Nigerian producer of value-added dairy and juice beverages and iced tea, in exchange for $260 million of cash, net of cash acquired, under the terms of the agreement for our original investment in CHI. Upon consolidation, we recognized a net charge of $121 million during the three months ended March 29, 2019, which included the remeasurement of our previously held equity interest in CHI to fair value and the reversal of the related cumulative translation adjustments. The fair value of our previously held equity investment was determined using a discounted cash flow model based on Level 3 inputs. The net charge was recorded in the line item other income (loss) net in our condensed consolidated statement of income.

Divestitures

During the three months ended March 27, 2020, proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $36 million, which primarily related to the sale of a portion of our ownership interest in one of our equity method investments. We recognized a net gain of $18 million as a result of the sale, which was recorded in the line item other income (loss) net in our condensed consolidated statement of income.

During the three months ended March 29, 2019, proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $261 million, which primarily related to the sale of a portion of our equity method investment in Embotelladora Andina S.A. ("Andina"). We recognized a gain of $39 million as a result of the sale, which was recorded in the line item other income (loss) net in our condensed consolidated statement of income. We continue to account for our remaining interest in Andina as an equity method investment as a result of our representation on Andina's Board of Directors and other governance rights.

NOTE 3: REVENUE RECOGNITION

The following table presents net operating revenues disaggregated between the United States and International and further by line of business (in millions):

United States

International

Total

Three Months Ended March 27, 2020

Concentrate operations

1,324

3,465

4,789

Finished product operations

1,483

2,329

3,812

Total

2,807

5,794

8,601

Three Months Ended March 29, 2019

Concentrate operations

1,185

3,593

4,778

Finished product operations

1,460

2,456

3,916

Total

2,645

6,049

8,694

Refer to Note 16 for additional revenue disclosures by operating segment and Corporate.

NOTE 4: INVESTMENTS

Equity Securities

The carrying values of our equity securities were included in the following line items in our condensed consolidated balance sheets (in millions):

Fair Value with Changes Recognized in Income

Measurement Alternative No Readily Determinable Fair Value

March 27, 2020

Marketable securities

275

Other investments

599

53

Other assets

889

Total equity securities

1,763

53

December 31, 2019

Marketable securities

329

Other investments

772

82

Other assets

1,118

Total equity securities

2,219

82

The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions):

Three Months Ended

March 27, 2020

March 29, 2019

Net gains (losses) recognized during the period related to equity securities

(396

147

Less: Net gains (losses) recognized during the period related to equity securities sold

during the period

(16

Net unrealized gains (losses) recognized during the period related to equity securities

still held at the end of the period

(380

140

Debt Securities

Our debt securities consisted of the following (in millions):

Gross Unrealized

Estimated Fair Value

Cost

Gains

Losses

March 27, 2020

Trading securities

33

(2

31

Available-for-sale securities

2,365

98

(4

2,459

Total debt securities

2,398

98

(6

2,490

December 31, 2019

Trading securities

46

47

Available-for-sale securities

3,172

113

(4

3,281

Total debt securities

3,218

114

(4

3,328

The carrying values of our debt securities were included in the following line items in our condensed consolidated balance sheets (in millions):

March 27, 2020

December 31, 2019

Trading Securities

Available-for-Sale Securities

Trading Securities

Available-for-Sale Securities

Cash and cash equivalents

97

123

Marketable securities

31

2,086

47

2,852

Other assets

276

306

Total debt securities

31

2,459

47

3,281

The contractual maturities of these available-for-sale debt securities as of March 27, 2020 were as follows (in millions):

Cost

Estimated

Fair Value

Within 1 year

1,374

1,393

After 1 year through 5 years

761

805

After 5 years through 10 years

58

68

After 10 years

172

193

Total

2,365

2,459

The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.

The sale and/or maturity of available-for-sale debt securities resulted in the following realized activity (in millions):

Three Months Ended

March 27, 2020

March 29, 2019

Gross gains

Gross losses

(2

(3

Proceeds

906

722

Captive Insurance Companies

In accordance with local insurance regulations, our captive insurance companies are required to meet and maintain minimum solvency capital requirements. The Company elected to invest a majority of its solvency capital in a portfolio of marketable equity and debt securities. These securities are included in the disclosures above. The Company uses one of its consolidated captive insurance companies to reinsure group annuity insurance contracts that cover the pension obligations of certain of our European and Canadian pension plans. This captive's solvency capital funds included equity and debt securities of $1,025 million as of March 27, 2020 and $1,266 million as of December 31, 2019, which are classified in the line item other assets in our condensed consolidated balance sheets because the assets are not available to satisfy our current obligations.

NOTE 5: INVENTORIES

Inventories consisted of the following (in millions):

March 27,

2020

December 31,

2019

Raw materials and packaging

2,282

2,180

Finished goods

901

851

Other

375

348

Total inventories

3,558

3,379

10

NOTE 6: HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS

The following table presents the fair values of the Company's derivative instruments that were designated and qualified as part of a hedging relationship (in millions):

Fair Value1,2

Derivatives Designated as Hedging Instruments

Balance Sheet Location1

March 27,

2020

December 31, 2019

Assets:

Foreign currency contracts

Prepaid expenses and other assets

140

24

Foreign currency contracts

Other assets

228

91

Interest rate contracts

Prepaid expenses and other assets

12

10

Interest rate contracts

Other assets

517

427

Total assets

897

552

Liabilities:

Foreign currency contracts

Accounts payable and accrued expenses

84

40

Foreign currency contracts

Other liabilities

231

48

Interest rate contracts

Other liabilities

23

21

Total liabilities

338

109

1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company's derivative instruments.

2 Refer to Note 15 for additional information related to the estimated fair value.

The following table presents the fair values of the Company's derivative instruments that were not designated as hedging instruments (in millions):

Fair Value1,2

Derivatives Not Designated as Hedging Instruments

Balance Sheet Location1

March 27,

2020

December 31, 2019

Assets:

Foreign currency contracts

Prepaid expenses and other assets

88

13

Foreign currency contracts

Other assets

Commodity contracts

Prepaid expenses and other assets

Commodity contracts

Other assets

Other derivative instruments

Prepaid expenses and other assets

12

Other derivative instruments

Other assets

Total assets

92

36

Liabilities:

Foreign currency contracts

Accounts payable and accrued expenses

130

39

Foreign currency contracts

Other liabilities

Commodity contracts

Accounts payable and accrued expenses

70

13

Commodity contracts

Other liabilities

28

Other derivative instruments

Accounts payable and accrued expenses

44

Total liabilities

276

53

1 All of the Company's derivative instruments are carried at fair value in our condensed consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company's derivative instruments.

2 Refer to Note 15 for additional information related to the estimated fair value.

Credit Risk Associated with Derivatives

We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring collateral for substantially all of our transactions. To mitigate presettlement risk, minimum credit standards become more stringent as the duration of the derivative financial instrument increases. In addition, the Company's master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same counterparty. To minimize the concentration of

11

credit risk, we enter into derivative transactions with a portfolio of financial institutions. Based on these factors, we consider the risk of counterparty default to be minimal.